Join
Live feed
·
INSIDERFilingvia Quantisnow
Eloxx Pharmaceuticals Inc. logo

Director Walts Alan Edmund converted options into 1,875 shares, increasing direct ownership by 14% to 15,567 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ELOX· Eloxx Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ELOX (Eloxx Pharmaceuticals Inc.) and more on Quantisnow.